DarioHealth Corp (NAS:DRIO)
$ 7.74 -0.45 (-5.78%) Market Cap: 75.41 Mil Enterprise Value: 87.22 Mil PE Ratio: 0 PB Ratio: 0.91 GF Score: 48/100

Q4 2024 DarioHealth Corp Earnings Call Transcript

Mar 10, 2025 / 12:30PM GMT
Release Date Price: $13.42 (-7.96%)

Key Points

Positve
  • DarioHealth Corp (DRIO) reported a 32.9% increase in total revenue for 2024, reaching $27 million, compared to $20.4 million in 2023.
  • The company's B2B2C recurring revenue from employers and health plans grew by approximately 400% year over year.
  • DarioHealth successfully integrated Twill, creating a comprehensive digital health platform supporting five chronic conditions.
  • The company achieved a gross margin above 80% for its B2B2C business over the last three quarters, indicating strong profitability.
  • DarioHealth plans to reduce operating expenses by an additional 20% by Q4 2025, aiming for cash flow breakeven by the end of 2025.
Negative
  • DarioHealth faces risks and uncertainties that could cause actual results to differ materially from forward-looking statements.
  • The company is not providing specific guidance for 2025, creating uncertainty about future financial performance.
  • DarioHealth's reliance on GLP-1 solutions for growth may pose a risk if market dynamics change or if the adoption rate slows.
  • The integration of behavioral health and metabolic solutions is still in progress, with no current accounts taking the full suite.
  • The company's revenue stability is challenged by the need to diversify its client base and reduce dependency on a few large accounts.
Operator

Good morning, ladies and gentlemen, and welcome to the DarioHealth fourth-quarter 2024 results conference call. (Operator Instructions) This call is being recorded on Monday, March 10, 2025.

I would now like to turn the conference over to Kat Parrella, Investor Relations Manager at Dario. Please go ahead.

Kat Parrella
DarioHealth Corp - Investor Relations Manager

Thank you, operator, and good morning, everyone. Thank you for joining us today for a discussion of DarioHealth's fourth-quarter and full-year 2024 financial results. Leading the call today will be Erez Raphael, Chief Executive Officer of DarioHealth. He'll be joined by Steven Nelson, Chief Commercial Officer.

An audio recording and webcast replay for today's call will also be available online, as detailed in the press release invite for this call. For the benefit of those who may be listening to the replay or archived webcast, this call is being held on Monday, March 10, 2025. This morning, we issued a press release announcing our financial results for the fourth quarter of 2024. A

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot